Abdel-Naeem Nareman M, Kandell Nagwa F, El-Shamaa Azza A, Harba Tarek M, Abdel-Hady Afaf A
Department of Internal Medicine, Faculty of Medicine for Girls, Al-Azhar University, Giza.
J Egypt Soc Parasitol. 2005 Dec;35(3 Suppl):1173-97.
Oxidative stress has been shown in (ESRD) patients specially those receiving regular haemodialysis (HD) in relation with an increased production of toxic free radicals due to membrane-induced complement leukocyte activation. An imbalance between oxidants and antioxidans has been suggested in uremic patients on HD. The respective influence of uremia and dialysis procedure has not been evaluated. Studies that have probed into the mechanism of oxygen radical production have implicated the bio-incompatibility of dialysis membranes. The effect of different dialysis membranes on lipid, lipoproteins, lipid peroxidation and total antioxidant capacity in ESRD patients on regular HD was studied. One hundred subjects were selected; 20 healthy controls, 20 chronic renal failure (CRF) patients on conservative drug management and 60 CRF patients on maintenance HD (20 dialyzed by polysulfone, 20 by hemophan and 20 by cuprophane membranes). All patients were matched for age, sex, gender and etiology of ESRD and HD patients for duration of dialysis. In addition to routine tests (Hb% and creatinine clearance in healthy control group and CRF patients on conservative management), total cholesterol, triglycerides, high density lipoprotein (HDL-C) and low density lipoprotein (LDL-C), apolipoprotein A (Apo A), apolipoprotein B (Apo B), serum malondialdehyde (MDA) and plasma total antioxidant status (TAS) were estimated. MDA was significantly higher and TAS was lower in uremic patients treated conservatively or by HD than in controls. MDA was significantly higher in HD than CRF patients on conservative management with least significant difference in HD patients treated by polysulfone followed by hemophan and then cuprophane membrane, while only cuprophane group showed lower levels of TAS compared to CRF patients on conservative management. HDL-C and Apo A was higher in polysulfone and hemophan than cuprophane group while triglyderide was lower. Polysulfone group showed lower levels of LDL-C than both cuprophane and hemophane groups thus providing less atherogenic lipid profile. There was a positive correlation between Hb% and TAS and a significant negative correlation between MDA and Hb%. There was a significant negative correlation between TAS and duration of dialysis in HD patients. In CRF patients on conservative management we obtained a significant positive correlation with TAS and a significant negative correlation with MDA.
氧化应激已在终末期肾病(ESRD)患者中被证实,尤其是那些接受定期血液透析(HD)的患者,这与因膜诱导补体白细胞激活导致的有毒自由基产生增加有关。有研究表明,接受血液透析的尿毒症患者体内氧化剂和抗氧化剂之间存在失衡。但尿毒症和透析过程各自的影响尚未得到评估。探究氧自由基产生机制的研究表明,透析膜的生物不相容性与此有关。本研究旨在探讨不同透析膜对接受定期血液透析的ESRD患者脂质、脂蛋白、脂质过氧化和总抗氧化能力的影响。研究选取了100名受试者,包括20名健康对照者、20名接受保守药物治疗的慢性肾衰竭(CRF)患者以及60名接受维持性血液透析的CRF患者(其中20名使用聚砜膜透析,20名使用血仿膜透析,20名使用铜仿膜透析)。所有患者在年龄、性别、ESRD病因以及血液透析患者的透析时长方面进行了匹配。除了常规检查(健康对照组和接受保守治疗的CRF患者的血红蛋白百分比和肌酐清除率)外,还测定了总胆固醇、甘油三酯、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)、载脂蛋白A(Apo A)、载脂蛋白B(Apo B)、血清丙二醛(MDA)和血浆总抗氧化状态(TAS)。接受保守治疗或血液透析的尿毒症患者的MDA显著高于对照组,而TAS则低于对照组。接受血液透析的患者的MDA显著高于接受保守治疗的CRF患者,其中使用聚砜膜透析的患者差异最小,其次是血仿膜,然后是铜仿膜;而只有使用铜仿膜透析的组与接受保守治疗的CRF患者相比,TAS水平较低。聚砜膜组和血仿膜组的HDL-C和Apo A高于铜仿膜组,而甘油三酯则较低。聚砜膜组的LDL-C水平低于铜仿膜组和血仿膜组,因此其脂质谱的动脉粥样硬化风险较低。血红蛋白百分比与TAS呈正相关,MDA与血红蛋白百分比呈显著负相关。血液透析患者的TAS与透析时长呈显著负相关。在接受保守治疗的CRF患者中,我们发现TAS与之呈显著正相关,MDA与之呈显著负相关。